MYWOT

Child safety

N/A

Confidence

0%

Trustworthiness

N/A

Confidence

0%

MALICIOUS CONTENT INDICATORS

Availability or unavailability of the flaggable/dangerous content on this website has not been fully explored by us, so you should rely on the following indicators with caution.

Kronosbio.com most likely does not offer any malicious content.

  • Siteadvisor

    Safety status

    N/A

  • SAFEBROWSING

    Safety status

    Safe

  • Phishtank

    Safety status

    N/A

Secure connection support

HTTPS

Kronosbio.com provides SSL-encrypted connection.

ADULT CONTENT INDICATORS

Availability or unavailability of the flaggable/dangerous content on this website has not been fully explored by us, so you should rely on the following indicators with caution.

Kronosbio.com most likely does not offer any adult content.

Audience

  • Bounce rate

    The accuracy of the provided data is based on the latest estimates available to us and can significantly differ from the real-life website stats, so should be taken with caution.

  • Time on site

    The accuracy of the provided data is based on the latest estimates available to us and can significantly differ from the real-life website stats, so should be taken with caution.

    00:56

    AVG

  • Gender

    The accuracy of the provided data is based on the latest estimates available to us and can significantly differ from the real-life website stats, so should be taken with caution.

    Men

    N/A

    Women

    N/A

Popular pages

  • Kronos Bio – Dedicated to discovery and development of novel small molecule modulators of

    Against challenging targets with a well-characterized role in cancer DEVELOP Via accelerated approval pathways (breakthrough or orphan designation) COMMERCIALIZE Pursuing therapies against some of the...

  • Company - Kronos Bio

    About Us We are a clinical-stage biopharmaceutical company dedicated to the discovery and development of therapeutics that target the dysregulated transcription that causes cancer and other serious di...

  • Science - Kronos Bio

    Our Science Dysregulated transcription is the hallmark of cancer Kronos Bio is focused on developing medicines that target dysregulated transcription factor activity, a hallmark of cancer and other se...

  • Open Positions - Kronos Bio

    Careers Join our team. We’re looking for individuals who want to join us as we seek to discover and develop new medicines. See our current list of openings below or submit your resume to careers@krono...

  • Clinical Trials - Kronos Bio

    Clinical Trials At Kronos Bio, we are actively recruiting patients for three clinical trials evaluating our investigational therapies for cancer. We encourage you to learn more below or reach out to u...

  • Publications - Kronos Bio

    Publications 2023 2022 2021 2020 2019 2018 2017 and older SLAS 2023 Walker, William, et. al., Small Molecule Microarray Screening Scale-Up and Automation at Kronos Bio ASH 2022 Carvajal, Luis A., et. ...

Open neighbouring websites list